Cargando…
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders()
The pathogen safety of blood/plasma-derived products has historically been a subject of significant concern to the medical community. Measures such as donor selection and blood screening have contributed to increase the safety of these products, but pathogen transmission does still occur. Reasons fo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115716/ https://www.ncbi.nlm.nih.gov/pubmed/26381318 http://dx.doi.org/10.1016/j.blre.2015.07.004 |
_version_ | 1783514155030937600 |
---|---|
author | Di Minno, Giovanni Perno, Carlo Federico Tiede, Andreas Navarro, David Canaro, Mariana Güertler, Lutz Ironside, James W. |
author_facet | Di Minno, Giovanni Perno, Carlo Federico Tiede, Andreas Navarro, David Canaro, Mariana Güertler, Lutz Ironside, James W. |
author_sort | Di Minno, Giovanni |
collection | PubMed |
description | The pathogen safety of blood/plasma-derived products has historically been a subject of significant concern to the medical community. Measures such as donor selection and blood screening have contributed to increase the safety of these products, but pathogen transmission does still occur. Reasons for this include lack of sensitivity/specificity of current screening methods, lack of reliable screening tests for some pathogens (e.g. prions) and the fact that many potentially harmful infectious agents are not routinely screened for. Methods for the purification/inactivation of blood/plasma-derived products have been developed in order to further reduce the residual risk, but low concentrations of pathogens do not necessarily imply a low level of risk for the patient and so the overall challenge of minimising risk remains. This review aims to discuss the variable level of pathogenic risk and describes the current screening methods used to prevent/detect the presence of pathogens in blood/plasma-derived products. |
format | Online Article Text |
id | pubmed-7115716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71157162020-04-02 Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() Di Minno, Giovanni Perno, Carlo Federico Tiede, Andreas Navarro, David Canaro, Mariana Güertler, Lutz Ironside, James W. Blood Rev Review The pathogen safety of blood/plasma-derived products has historically been a subject of significant concern to the medical community. Measures such as donor selection and blood screening have contributed to increase the safety of these products, but pathogen transmission does still occur. Reasons for this include lack of sensitivity/specificity of current screening methods, lack of reliable screening tests for some pathogens (e.g. prions) and the fact that many potentially harmful infectious agents are not routinely screened for. Methods for the purification/inactivation of blood/plasma-derived products have been developed in order to further reduce the residual risk, but low concentrations of pathogens do not necessarily imply a low level of risk for the patient and so the overall challenge of minimising risk remains. This review aims to discuss the variable level of pathogenic risk and describes the current screening methods used to prevent/detect the presence of pathogens in blood/plasma-derived products. Published by Elsevier Ltd. 2016-01 2015-07-20 /pmc/articles/PMC7115716/ /pubmed/26381318 http://dx.doi.org/10.1016/j.blre.2015.07.004 Text en Copyright © 2015 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Di Minno, Giovanni Perno, Carlo Federico Tiede, Andreas Navarro, David Canaro, Mariana Güertler, Lutz Ironside, James W. Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
title | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
title_full | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
title_fullStr | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
title_full_unstemmed | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
title_short | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
title_sort | current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders() |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115716/ https://www.ncbi.nlm.nih.gov/pubmed/26381318 http://dx.doi.org/10.1016/j.blre.2015.07.004 |
work_keys_str_mv | AT diminnogiovanni currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders AT pernocarlofederico currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders AT tiedeandreas currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders AT navarrodavid currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders AT canaromariana currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders AT guertlerlutz currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders AT ironsidejamesw currentconceptsinthepreventionofpathogentransmissionviabloodplasmaderivedproductsforbleedingdisorders |